Focused Issue on Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting

Posted On 2019-08-13 09:29:40


This focused issue about the Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting is edited by Dr. Sanja Dacic, Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.

Dr. Sanja Dacic is a Thoracic Pathologist and Professor of Pathology at the University of Pittsburgh Medical Center. Her clinical work includes all diagnostic aspects of neoplastic and non-neoplastic thoracic pathology including lung transplantation. Her research work is primarily focused on prognostic and predictive biomarkers in lung cancer and malignant mesotheliomas. She is a member of the International Association for the Study of Lung Cancer (IASLC) Pathology Committee, International Mesothelioma Interest Group, and the US and Canadian Mesothelioma Panel. She currently serves as a vice-president of the Pulmonary Pathology Society. She held leadership positions at the United States and Canadian Academy of Pathology including member of the Education Committee (2011-2015), member of the Board of Directors (2015-2018), and chair of the Young Investigator Awards Committee (2015-2018). She is a co-author of the 4th edition of WHO classification of the lung tumors, the CAP/AMP/IASLC guideline for molecular testing in lung carcinoma and the diagnostic mesothelioma guideline. She is the Deputy Chief Editor for Archives of Pathology and Laboratory Medicine.

Focused issue outline:

1. Controversies in histologic subtyping of lung adenocarcinomas

2. Clinical significance of spread through airspaces (STAS)

3. Multiple faces of large cell neuroendocrine carcinoma  

4. Lung cancer biomarker testing-perspective from Asia

5. Lung cancer biomarker testing-perspective from Europe

6. Molecular testing for predictive biomarkers in lung cancer on cytology specimens

7. PD-L1 harmonization studies

8. Update on pathologic diagnosis of malignant mesothelioma

9. Clinical significance of histologic subtyping of malignant mesothelioma

10. Diagnosis of pleural mesothelioma on cytology